Search

Reserved

Reserve their space

Breast Cancer Research Image Competition 2017

I am more than my cancer

When Kit was initially diagnosed with secondary breast cancer at the age of 33, she was shocked. She explains why she refuses to let her cancer define her.

Diet and metastatic breast cancer

Learn about diet and metastatic (secondary) breast cancer, including whether you need supplements and how to manage changes to your diet.

Using AI to uncover the causes of late recurrence in ER-positive breast cancer

Dr Maggie Cheang

I’m raising funds to help people like me

2 months after her primary breast cancer diagnosis, Paula got the news she had secondary breast cancer. Keeping a positive mindset, Paula’s not letting it stop her and enjoying life as it comes. This year, she’s taking on a Pink Ribbon Walk so more people like her can get support.

Triple negative breast cancer – how research is changing the future

Thanks to research, we now know more about triple negative breast cancer and are finding kinder and smarter ways to treat it.

In memory of my beautiful wife Gill, I’m teeing off 100 holes in a single day

When David's wife, Gill, was diagnosed with breast cancer in 2018, their lives changed forever. Now, in Gill's memory, David and his friends are taking on an ambitious golfing challenge, pushing themselves to raise vital funds for cancer charities like Breast Cancer Now. They've already raised over £100,000 and are determined to go even further.

Samina

"Today I stand tall as a confident Pakistani Muslim woman. Above all, cancer has taught me to learn self-love unapologetically."

Research sheds light on inequalities in breast cancer diagnosis and treatment

Our scientists identified which groups of people with breast cancer are less likely to be diagnosed through screening and more likely to face delays in diagnosis and treatment. Together, we’re identifying where action is needed and tackling inequalities in breast cancer care.

Ribociclib (Kisqali)

Learn about the targeted therapy ribociclib (Kisqali), including whether you might be offered it, how it’s given and the side effects you could have.

We respond to NICE’s provisional rejection of capivasertib with fulvestrant for certain types of secondary breast cancer

Claire Rowney, chief executive of Breast Cancer Now, said: